{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T05:30:19Z","timestamp":1761975019123,"version":"3.44.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,1,1]],"date-time":"2008-01-01T00:00:00Z","timestamp":1199145600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2008,1]]},"DOI":"10.1016\/j.jaci.2007.11.019","type":"journal-article","created":{"date-parts":[[2008,1,16]],"date-time":"2008-01-16T11:31:41Z","timestamp":1200483101000},"page":"272-280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["New therapies for hereditary angioedema: Disease outlook\u00a0changes dramatically"],"prefix":"10.1016","volume":"121","author":[{"given":"Michael M.","family":"Frank","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haixiang","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2007.11.019_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.7326\/0003-4819-53-4-739","article-title":"Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema)","volume":"53","author":"Spaulding","year":"1960","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib2","first-page":"1","article-title":"Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year's clinical experience","volume":"448","author":"Nilsson","year":"1966","journal-title":"Acta Med Scand Suppl"},{"key":"10.1016\/j.jaci.2007.11.019_bib3","first-page":"733","article-title":"A case of hereditary angioneurotic oedema, successfully treated with epsilon-aminocaproic acid: studies on C'1 esterase inhibitor, C'1 activation, plasminogen level and histamine metabolism","volume":"7","author":"Lundh","year":"1968","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2007.11.019_bib4","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/j.1365-2133.1969.tb15938.x","article-title":"Hereditary angio-oedema treated with E-aminocaproic acid","volume":"10","author":"Champion","year":"1969","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaci.2007.11.019_bib5","first-page":"1235","article-title":"Epsilon aminocaproic acid for hereditary angioedema","volume":"21","author":"Frank","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib6","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1056\/NEJM197208312870907","article-title":"Tranexamic acid therapy in hereditary angioneurotic edema","volume":"9","author":"Sheffer","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib7","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.0954-6820.1972.tb04818.x","article-title":"Treatment of hereditary angioneurotic oedema with tranexamic acid: a random double-blind cross-over study","volume":"4","author":"Blohme","year":"1972","journal-title":"Acta Med Scand"},{"key":"10.1016\/j.jaci.2007.11.019_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.7326\/0003-4819-84-5-580","article-title":"Hereditary angioedema: the clinical syndrome and its management","volume":"5","author":"Frank","year":"1976","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib9","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","article-title":"Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities","volume":"26","author":"Gelfand","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib10","first-page":"391","article-title":"Long-term therapy of hereditary angioedema (HAE): preventive management with fluoxymesterone and oxymetholone in severely affected males and females","volume":"6","author":"Davis","year":"1974","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/j.jaci.2007.11.019_bib11","first-page":"122","article-title":"The effect of synthetic androgens in hereditary angioneurotic edema: alteration of C1 inhibitor and C4 levels","volume":"LXXXIX","author":"Rosse","year":"1976","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/j.jaci.2007.11.019_bib12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/0091-6749(81)90181-0","article-title":"Clinical and biochemical effects of stanozolol therapy for hereditary angioedema","volume":"3","author":"Sheffer","year":"1981","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2007.11.019_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0002-9343(63)90162-1","article-title":"A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C' 1-esterase","volume":"35","author":"Donaldson","year":"1963","journal-title":"Am J Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1034\/j.1399-3038.2002.01014.x","article-title":"Clinical management of hereditary angio-oedema in children","volume":"3","author":"Farkas","year":"2002","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/j.jaci.2007.11.019_bib15","first-page":"474","article-title":"Ambiguous genitalia in a term infant due to exposure to danazol in utero","volume":"136","author":"Schwartz","year":"1982","journal-title":"Am J Dis Child"},{"key":"10.1016\/j.jaci.2007.11.019_bib16","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S0015-0282(16)53638-3","article-title":"The long-term safety of danazol in women with hereditary angioedema","volume":"1","author":"Zurlo","year":"1990","journal-title":"Fertil Steril"},{"key":"10.1016\/j.jaci.2007.11.019_bib17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S0140-6736(73)90098-6","article-title":"Androgens and hepatocellular carcinoma","volume":"7797","author":"Ziegenfuss","year":"1973","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2007.11.019_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S0168-8278(02)00035-1","article-title":"Danazol-induced hepatocellular adenoma in patients with hereditary angio-oedema","volume":"5","author":"Bork","year":"2002","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaci.2007.11.019_bib19","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0168-8278(98)80140-2","article-title":"Danazol therapy: an unusual aetiology of hepatocellular carcinoma","volume":"6","author":"Crampon","year":"1998","journal-title":"J Hepatol"},{"key":"10.1016\/j.jaci.2007.11.019_bib20","first-page":"298","article-title":"Complement inactivation by serum from patients with acute and hypocomplementemic chronic glomerulonephritis","volume":"2","author":"Pickering","year":"1968","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.clim.2004.05.007","article-title":"The pathophysiology of hereditary angioedema","volume":"1","author":"Davis","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.jaci.2007.11.019_bib22","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198705283162202","article-title":"Autoantibody-mediated acquired deficiency of C1 inhibitor","volume":"22","author":"Alsenz","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib23","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1056\/NEJM198003063021002","article-title":"Replacement therapy in hereditary angioedema: successful treatment of acute episodes of angioedema with partly purified C1 inhibitor","volume":"10","author":"Gadek","year":"1980","journal-title":"N Engl J\u00a0Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib24","first-page":"526","article-title":"(1980) C1-inhibitor concentrate for treatment of hereditary angioedema","volume":"9","author":"Agostoni","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib25","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.iac.2006.09.007","article-title":"Novel therapies for hereditary angioedema","volume":"4","author":"Zuraw","year":"2006","journal-title":"Immunol Allergy Clin North Am"},{"key":"10.1016\/j.jaci.2007.11.019_bib26","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0028-1103919","article-title":"Hereditares angioneurotisches Odem. Klinik sowie erweiterte diagnostische und therapeutische Moglichkeiten","volume":"11","author":"Bork","year":"1979","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/j.jaci.2007.11.019_bib27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1001\/archinte.161.5.714","article-title":"Treatment of 193 episodes of laryngeal edema with C1 inhibitor concentrate in patients with hereditary angioedema","volume":"5","author":"Bork","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib28","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1111\/j.1537-2995.2005.00602.x","article-title":"Treatment with C1 inhibitor concentrate in abdominal pain attacks of patients with hereditary angioedema","volume":"11","author":"Bork","year":"2005","journal-title":"Transfusion"},{"key":"10.1016\/j.jaci.2007.11.019_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S1473-0502(03)00164-2","article-title":"How do we treat patients with hereditary angioedema","volume":"3","author":"Cicardi","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jaci.2007.11.019_bib30","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","article-title":"Treatment of hereditary angioedema with a\u00a0vapor-heated C1 inhibitor concentrate","volume":"334","author":"Waytes","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2007.11.019_bib31","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/j.1572-0241.2006.00492.x","article-title":"Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency","volume":"3","author":"Bork","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jaci.2007.11.019_bib32","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jaci.2006.01.002","article-title":"Self-administration of C1-inhibitor concentrate in patients with hereditary or acquired angioedema caused by C1-inhibitor deficiency","volume":"4","author":"Levi","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2007.11.019_bib33","first-page":"11","article-title":"C1-inhibitor concentrate home therapy for hereditary angioedema: a viable, effective treatment option","volume":"1","author":"Longhurst","year":"2007","journal-title":"Clin Exp Immunol"},{"issue":"Suppl","key":"10.1016\/j.jaci.2007.11.019_bib34","doi-asserted-by":"crossref","first-page":"S106","DOI":"10.1007\/BF02680006","article-title":"Enzyme therapy for Pompe disease: from science to industrial enterprise","author":"Reuser","year":"2002","journal-title":"Eur J Pediatr"},{"key":"10.1016\/j.jaci.2007.11.019_bib35","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaci.2005.05.019","article-title":"A phase I study of recombinant human C1 inhibitor in asymptomatic patients with hereditary angioedema","volume":"4","author":"van Doorn","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2007.11.019_bib36","first-page":"51","article-title":"N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits","volume":"1","author":"Koles","year":"2004","journal-title":"Glycobiology"},{"key":"10.1016\/j.jaci.2007.11.019_bib37","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S1473-0502(03)00170-8","article-title":"DX-88 and HAE: a developmental perspective","volume":"3","author":"Williams","year":"2003","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.jaci.2007.11.019_bib38","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1517\/13543784.15.9.1077","article-title":"The therapeutic potential of a kallikrein inhibitor for treating hereditary angioedema","volume":"15","author":"Levy","year":"2006","journal-title":"Exp Opin Investig Drugs"},{"key":"10.1016\/j.jaci.2007.11.019_bib39","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0165-2478(03)00130-5","article-title":"Approaches toward reversal of increased vascular permeability in C1 inhibitor deficient mice","volume":"2-3","author":"Han Lee","year":"2003","journal-title":"Immunol Lett"},{"key":"10.1016\/j.jaci.2007.11.019_bib40","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jaci.2007.04.028","article-title":"Critical role of kallikrein in hereditary angioedema pathogenesis: a clinical trial of Ecallantide, a novel kallikrein inhibitor","volume":"2","author":"Schneider","year":"2007","journal-title":"J Allergy Clin Immunol"},{"year":"2007","author":"Levy","series-title":"Results of a phase 3 double-blind, placebo-controlled trial, EDEMA 3: a study of subcutaneous DX88 (Ecallantide) in patients with hereditary angioedema","key":"10.1016\/j.jaci.2007.11.019_bib41"},{"key":"10.1016\/j.jaci.2007.11.019_bib42","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaci.2005.10.045","article-title":"Anaphylactic reaction and antibodies to DX-88 (kallikrein inhibitor) in a patient with hereditary angioedema","volume":"2","author":"Caballero","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2007.11.019_bib43","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1111\/j.1398-9995.2006.01197.x","article-title":"Novel pharmacotherapy of acute hereditary angioedema with bradykinin B2-receptor antagonist icatibant","volume":"12","author":"Bas","year":"2006","journal-title":"Allergy"},{"key":"10.1016\/j.jaci.2007.11.019_bib44","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jaci.2007.02.012","article-title":"Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant)","volume":"6","author":"Bork","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jaci.2007.11.019_bib45","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1172\/JCI200214211","article-title":"Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor","volume":"8","author":"Han","year":"2002","journal-title":"J Clin Invest"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674907022671?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674907022671?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T05:13:30Z","timestamp":1758777210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674907022671"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,1]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2008,1]]}},"alternative-id":["S0091674907022671"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2007.11.019","relation":{},"ISSN":["0091-6749"],"issn-type":[{"type":"print","value":"0091-6749"}],"subject":[],"published":{"date-parts":[[2008,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New therapies for hereditary angioedema: Disease outlook\u00a0changes dramatically","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2007.11.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Academy of Allergy, Asthma & Immunology. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}